KCNJ10 and Alzheimer disease: These findings align with previous studies showing reduced Kir4.1 mRNA levels in the medial temporal lobe of AD patients and with severe amyloid angiopathy, as well as reduced Kir4.1 mRNA and protein in APPSwDI/NOS2−/− and APPSwDI mice (Wilcock et al. 2009).